Amyris Competitors and Similar CompaniesClear all
Amyris's competitors and similar companies include MECS, Mirimus, Editas Medicine and Caribou Biosciences.
 Amyris Amyris is a biotechnology company that develops chemical ingredients using microbial fermentation. |  MECS MECS (Monsanto Enviro-Chem Systems) is a company that provides process technology, proprietary specialty equipment, and technical services for sulfuric acid producers. |  Mirimus Mirimus is a company that specializes in biotech and preclinical CRO solutions based on genetical engineering. |  Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. |  Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | |
Founding Date | Founding Date 2003 | Founding Date 1992 | Founding Date 2010 | Founding Date 2013 | Founding Date 2012 |
Type | Type Private | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Emeryville, US HQ Sao Paulo, BR | Locations Chesterfield, US HQ | Locations Brooklyn, US HQ | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Berkeley, US HQ |
Employees | Employees 1,0031% decrease | Employees 573 | Employees 63 | Employees 20816% increase | Employees 1477% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 256.5 m | Valuation ($) 174.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $269.8m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $40.5m (FY, 2025) | Revenue (est.) $11.2m (FY, 2025) |
Net income | Net income ($543.4m) (FY, 2022) | Net income N/A | Net income N/A | Net income ($160.1m) (FY, 2025) | Net income ($148.1m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round $ 34m (about 7 years ago) | Latest funding round N/A | Latest funding round $ 2m (about 15 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 551.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 210m | Total funding raised $ 159.5m |
For sources of this data, please see the company profile
View Company Profiles
MECS
HQ
Chesterfield, US
MECS (Monsanto Enviro-Chem Systems) is a company that provides process technology, proprietary specialty equipment, and technical services for sulfuric acid producers.
View companyMirimus
HQ
Brooklyn, US
Employees
63
Mirimus is a company that specializes in biotech and preclinical CRO solutions based on genetical engineering.
View companyEditas Medicine
HQ
Cambridge, US
Employees
208↑ 16% increase
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
View companyCaribou Biosciences
HQ
Berkeley, US
Employees
147↓ 7% decrease
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
View company